The plakophilins, members of the armadillo-repeat family, consist of three different proteins (PKP1-3) that are specifically recruited to desmosomal plaques in a highly cell type-specific manner. Using immunofluorescence, immunoelectron microscopy, and immunoblot, we found that all three plakophilins occurred in luminal and basal cells of the pseudostratified prostate epithelium. The analysis of 135 cases of prostatic adenocarcinomas grouped into tumors with low (Gleason score < 6), intermediate (Gleason score 7), and high Gleason score (8 < Gleason score < 10) showed that the expression of PKP1 was reduced or lost in adenocarcinomas with high Gleason scores. The expression of PKP2 was unchanged in all prostatic adenocarcinomas analyzed. In contrast, PKP3 expression was increased in carcinomas with high Gleason scores in comparison with carcinomas with low Gleason scores. In DU 145 cell lines with either overexpression or knockdown of PKP3, both imbalances resulted in fewer desmosomal cell contacts. In addition, overexpression of PKP3 in DU 145 cells led to an augmentation in proliferation rate. Our data imply that both loss of PKP1 and up-regulation of PKP3 expression are biologically important events in prostate cancer and are associated with a more ag-
plaques in a highly cell type-specific manner. Protein p0071, also called PKP4, is more closely related to other members of the p120 subfamily and is localized as a nondesmosomal plaque protein in adherens junctions. 8, 9 Only PKP2 has been detected in all desmosome-producing cell types, including simple and stratified epithelia as well as nonepithelial tissues such as myocardium and lymph node follicles. 5, 10 In contrast, PKP1 is restricted to stratified and complex epithelia and urothelium, 11 whereas PKP3 is located in almost all desmosome-bearing cells, with the exception of desmosomes between hepatocytes and between cardiomyocytes. 12, 13 Prostate cancer is the most frequent malignancy in men of the western civilization and early detection is essential to reduce mortality and increase survival. In recent years, evidence has been accumulated that several junctional proteins play important roles in carcinogenesis, tumor invasion and metastasis. As a prototypic example, ␤-catenin mutations in colorectal carcinomas result in impaired ␤-catenin degradation 14 with profound effects on downstream signaling pathways. Loss, downregulation, or mislocalization of another important junctional protein, protein p120, has been found to correlate with tumor progression. 15 In contrast, the potential role of plakophilins in human tumorigenesis and progression is largely unexplored. A few immunohistochemical studies on squamous cell carcinoma suggested a correlation with clinical parameters 16 -18 and point to a potentially important role. In the past, the occurrence of PKPs in normal prostate epithelium and in prostatic adenocarcinoma has not been analyzed. Therefore, we performed immunofluorescence and immunoelectron microscopy to study the distribution of PKP1-3 in human prostate. All three PKPs were detectable in normal luminal and basal cells of glandular prostatic epithelium. The analysis of adenocarcinomas of the prostate together with observations in prostatic cell lines with either overexpression or knockdown of PKPs implies that loss of PKP1 and up-regulation of PKP3 expression are biologically important events in prostate cancer. 8, 9 mAb, m Clone 406.3.1 (Progen Biotechnik) 8, 9 As, gp hp0071 (Progen Biotechnik) 8, 9 ARVCF As, gp 2ϫ hARVCF (Progen Biotechnik) 23 As 
Materials and Methods

Cultured Cells and Tissues
Cell cultures derived from prostatic hyperplasia and metastases used in this study were the benign cell line BPH-1 19 and the malignant cell lines DU 145 and LNCaP (for further information on cell lines, see the catalog of the American Tissue Culture Collection, Manassas, VA). The BPH-1 cell line was cultivated in RPMI 1640 medium (Invitrogen, Karlsruhe, Germany) with 1% glutamine (Invitrogen), 10% fetal bovine serum (Biochrom, Berlin, Germany), 1 g/ml insulin (Sanofi-Aventis, Frankfurt, Germany), 20 ng/ml testosterone (Sigma-Aldrich, Steinheim, Germany), 5 g/ml transferrin (Sigma-Aldrich), and 10 ng/ml hydrocortisone (Fluka, Steinheim, Germany). The cell lines DU 145 and LNCaP were cultivated in RPMI 1640 medium with 10% fetal bovine serum and 1% glutamine. Tumor-free human prostatic tissue samples were obtained from tumor prostatectomies at the Department of Urology, Medical Faculty Heidelberg and Medical Fac- 
Antibodies
The primary antibodies used in this study are listed in Table 1 . 5, 6, 8, 9, 11, 13, [22] [23] [24] 39 Details on references and distributors can also be found in Table 1 . 5, 6, 8, 9, 11, 13, [22] [23] [24] 39 Secondary antibodies used for immunofluorescence microscopy were species-specific goat antibodies against Igs of guinea pig, mouse, or rabbit conjugated to Cy3 (BioTrend, Cologne, Germany) or Alexa 488 (MoBiTec, Gö ttingen, Germany). For immunoblot analysis, horseradish peroxidase-conjugated secondary antibodies were applied in combination with the enhanced chemiluminescence system (AceGlow-Solution; PEQLAB Biotechnologie, Erlangen, Germany).
Immunofluorescence Microscopy and Immunoelectron Microscopy
The methods used for single-and double-label antibody immunofluorescence microscopy on sections of frozen tissues and cultured cells were described in detail elsewhere. 8 For sectioning of paraffin-embedded tissues (3 to 5 m), a microtome (HM 430; Microm, Walldorf, Germany) was used. Briefly, sections were deparaffinized according to standard techniques and thereafter pretreated to retrieve masked antigens (0.05 M Tris-HCl buffer, pH 10.2, 12 minutes, 120°C for detection of PKP1, PKP2, and ARVCF and 0.1 M Tris buffer containing 10% urea, pH 11, 15 minutes, 120°C for detection of PKP3, protein p0071, and protein p120) with a multifunctional microwave processor (RHS-1; Milestone, Sorisole, Italy). Alternatively, the samples were heated in their appropriate buffer either with a standard microwave (Panasonic, Hamburg, Germany) at 600 W or a steamer (Braun, Kronberg, Germany) for 25 minutes. Sections were then treated with 0.2% Triton X-100 in PBS for 5 minutes, washed with PBS (twice 5 minutes), blocked with 5% goat serum and 2% milk powder in PBS (10 minutes), and then processed for immunofluorescence microscopy. For PKP1 and PKP2 staining sections were additionally incu- bated before blocking with 2 g/ml proteinase K (DakoCytomation, Hamburg, Germany) for 8 minutes at 37°C, followed by 8 minutes at room temperature. The PKP1-3-specific antibodies were incubated for 4 hours at room temperature (PKP1 and PKP2) or overnight at 4°C (PKP3), the secondary antibodies for 1 hour. As control for unspecific binding, incubation with primary antibody was omitted, and the specimens were incubated with secondary antibody only. Micrographs were taken with an Axiophot microscope (Zeiss, Jena, Germany). Confocal laser scanning immunofluorescence microscopy was done on a Zeiss LSM 510 UV instrument (Zeiss) as described before. 25 Procedures used for conventional electron microscopy and immunoelectron microscopy were as described in detail elsewhere. 26 
Interpretation of Immunfluorescence Signal
A representative section of each tumor sample was stained with H&E to verify tumor classification and to proof the quality of the tissue sample by light microscopy. The extent of immunofluorescence signal was subclassified as homogeneous (staining of the whole tumor) or inhomogeneous (staining only in defined tumor areas). Immunofluorescence experiments were conducted with a negative control for each tumor sample by omitting primary antibody. In addition, an internal control representing nonneoplastic prostate tissue was included. Depending on the percentage of positive cells, the immune reactions were scored into negative (Ͻ5% positive staining), inhomogeneous (5% Յ positive staining Յ 90%), and positive (Ͼ90% positive staining). Immunofluorescence evaluation was performed and photographs were taken with an Axiophot microscope (Zeiss).
Statistical Analyses
Statistical differences between categoric variables were determined using Yates corrected 2 test. Correlations between parameters in ordinal scales were analyzed by Spearman rank R test, as provided by the SPSS software (version 2000; SPSS, Chicago, IL). For all analyses, a value of P Ͻ 0.05 was considered significant, unless otherwise stated.
Gel Electrophoresis and Immunoblotting
Lysates were generated by the addition of Laemmli sample buffer substituted with Benzonase (Merck, Darmstadt, Germany) to cells or tissues. For immunoblot, proteins decorated with specific primary and secondary antibodies were detected by applying the enhanced chemiluminescence system to the membranes. Light emission was recorded by a photomultiplier in a gel documentation system (ChemiSmart 5000; PEQLAB Biotechnologie).
RNA Isolation and Real-Time PCR
RNA from cells was isolated using a RNA isolation kit (RNAeasy; Qiagen, Hilden, Germany). Afterward, a RT-PCR was performed to transcribe RNA into cDNA (High Capacity cDNA Reverse Transcription kit; Applied Biosystems, Darmstadt, Germany). The obtained cDNA was diluted 1/5 for real-time PCR and added to the Power SYBR Green PCR Master Mix (Applied Biosystems). Primers against PKP1 (sequence forward: 5Ј-GACCAGGACAACTCCACGTT-3Ј, reverse: 5Ј-CTGCTGGTGGTCCCATAGTT-3Ј), PKP2 (sequence forward: 5Ј-GCAAATGGTTTGCTCGATTT-3Ј, reverse: 5Ј-GGCTGGTAATCTGCAATGGT-3Ј), and PKP3 (sequence forward: 5Ј-TGATGAGCTTCGCAAAAATG-3Ј, reverse: 5Ј-CT-GAGAGGCTGAGCTGAGGT-3Ј) were used, and the occurrence of corresponding DNA fragments was analyzed via StepOnePlus Real-Time PCR System (Applied Biosystems) and controlled by electrophoresis in 1% agarose gels. Hypoxanthine-guanine phosphoribosyltransferase RNA levels were used as internal reference to evaluate RNA recovery and to exclude variations between the different cell clones.
Generation of cDNA Constructs, Transfections, and Generation of Stable Cell Lines
The PKP3-pEGFP-N1 construct 27 was cloned into the pLenti6.2/V5-DEST plasmid (Invitrogen) via the pENTR3C plasmid using restriction sites EcoRI and EcoRV, followed by Clonase reaction as specified by the manufacturer. As a negative control a pLenti-IRES-EGFP plasmid containing enhanced green fluorescent protein (EGFP) only was used (provided by A. Fischer, CBTM). Additionally, a PKP3-myc tag construct was created by replacing the EGFP tag with annealed oligonucleotides coding for the myc tag (5Ј-CG-GAGCAGAAACTCATCTCAGAAGAGGATCTGTGGT-3Ј and 5Ј-CTAGATTACAGATCCTCTTCTGAGATGAGTTTCTGCTC-CGGTAC-3Ј) in the PKP3-pEGFP-N1 vector.
To generate PKP3-specific short hairpin (sh)RNAs, oligonucleotides against different PKP3-mRNA targeting sites were synthesized (shPKP3-9: 5Ј-GTACCTCGGGACAG-GACGTGAAGATAGTTCAAGAGACTATCTTCACGTCCTG-TCCCTTTTTGGAAA-3Ј and 5Ј-AGCTTTTCCAAAAAGGG-ACAGGACGTGAAGATAGTCTCTTGAACTATCTTCACGTC-CTGTCCCGAG-3Ј; shPKP3-1350: 5Ј-GTACCTCGGATCC-TGTGGAACCTTTCATTCAAGAGATGAAAGGTTCCACAG-GATCCTTTTTGGA-3Ј; and 5Ј-AGCTTTTCCAAAAAGGAT-CCTGTGGAACCTTTCATCTCTTGAATGAAAGGTTCCAC-AGGATCC-3Ј). The annealed oligonucleotides were ligated directly into the psiRNA-h7SKZeo plasmid (InvivoGen, Toulouse, France) using the unique Acc65I and HindIII restriction sites. As a negative control, a shRNA construct against Luciferase, shLuc, was used (InvivoGen).
The pLenti-PKP3-EGFP plasmid and the pLenti-EGFP plasmid were stably transduced into DU 145 cells according to the protocol of the manufacturer (Invitrogen), and cells were selected with 10 g/ml blasticidin (Invitrogen). For generation of stable PKP3 knockdown cell clones and of the negative control cell clone, shLuciferase, DU 145 cells were transfected with the corresponding shRNA plasmids using Fugene 6 transfection reagent (Roche, Mannheim, Germany), followed by selection with 100 g/ml Zeocin (Invitrogen). For selection of plasmid containing cell clones, the expression of EGFP was analyzed. A transient transfection with the PKP3-myc construct was also performed with Fugene 6 transfection reagent.
Proliferation Assay
DU 145 wild-type, PKP3 knockdown (shPKP3-1350), and PKP3 overexpressing (PKP3-EGFP) cells were seeded in a 96-well plate (6 ϫ 10 2 cells/well). 5-Bromo-2Ј-deoxyuridine (BrdU) was added 48 hours later. Incorporation of BrdU was determined after another 24 hours, according to the protocol of the manufacturer (Cell Proliferation ELISA, BrdU (colorimetric); Roche). Absorbance at 400 nm (reference wavelength, 492 nm) was measured using an ELISA reader (Tecan, Crailsheim, Germany). Statistical differences in proliferation between cell culture lines were analyzed using Student's t-test for unpaired experiments.
Results
The Presence of Plakophilins in Normal Prostate
To characterize the occurrence of arm-repeat proteins of the p120 subfamily in normal prostate, we systematically screened human tumor-free prostate by immunofluorescence on cryosections using antibodies specific for protein p120, ARVCF, protein p0071, neurojungin, and plakophilins 1-3. Thereby, we noticed a strong staining of the glandular epithelium for all members of the p120 subfamily with the exception of neurojungin (data not shown). According to previous reports, 2,5,11,13 the occurrence of all three plakophilins in the glandular epithelium of the prostate, especially of PKP1, was unexpected, and therefore, we followed this observation in more detail. We compared the localization PKP1-3 with that of other desmosomal plaque proteins (eg, desmoplakin) and desmosomal transmembrane proteins (eg, desmoglein) and found for all three plakophilins colocalization with desmosomal marker proteins (Figure 1) . All proteins showed a punctuate staining at cell borders and a pronounced accumulation at the apical portion of basolateral membranes typical for polar epithelia. The glandular epithelium of the prostate consists of luminal cells revealing secretory activity and stretched basal cells. By careful inspection at higher magnification, the basal cells were seen to be labeled by antibodies specific for PKP1-3. To unequivocally clarify if all three plakophilins occur in basal cells, we used antibodies specific for keratin 14, a marker for basal cells, and keratin 8 and keratin 18, markers for luminal and basal cells, 28 and compared the localization with that of PKP1-3. To obtain better structural preservation, we used immunofluorescence on formaldehyde-fixed and paraffin-embedded tumor-free human prostate samples. Indeed, antibodies against all three plakophilins convincingly showed a decoration of both basal and luminal cells (Figure 2 and Supplemental Figure 1, see http: //ajp.amjpathol.org). We also applied immunoelectron microscopy to verify the observation that all three plakophilins occur in the glandular epithelium of the prostate at the ultrastructural level (Figure 3) . Antibodies against all three plakophilins decorated desmosomal plaques of neighboring epithelial cells in the glandular epithelium of prostate showing the typical appearance of desmosomes with a cytoplasmic electrodense plaque where intermediate filaments are inserted.
The Detection of Plakophilins in Cultured Cells Derived from Prostatic Tissue
We compared our results obtained on human prostatic normal tissue with cultured cells derived from human prostate. Cell cultures derived from prostatic hyperplasia (eg, BHP-1 cells) and metastases (eg, LNCaP cells isolated from lymph node metastases and DU 145 cells derived from a brain metastasis) were used, and immunoblotting using antibodies specific for the plakophilins, PKP1-3, was performed. Although all three plakophilins were detectable in lysates from prostatic tissue and from the benign cell line (BPH-1), only PKP3 showed a prominent reaction in lysates from both malignant cell lines, LNCaP and DU 145 (Figure 4 ). In contrast, PKP2 was barely traceable in LNCaP and DU 145 cells, and PKP1 was not detectable in these cell lines. We verified these observations by immunofluorescence microscopy and found that PKP3 and PKP2 were detectable in desmosomes in all cell lines, whereas PKP1 was only observed in the benign cell line BPH-1 (data not shown). Moreover, we performed RT-PCR on DU 145 cells and found mRNA expression of PKP3 (Supplemental Figure 2, see http: // ajp.amjpathol.org) and PKP2 but not of PKP1 (data not shown).
The Plakophilins in Adenocarcinomas of the Prostate
Because not all three plakophilins were detectable in malignant prostatic cell lines, we wondered whether the loss of plakophilins correlates with different tumor characteristics. Therefore, we systematically analyzed 135 prostatic adenocarcinomas with different Gleason scores (n ϭ 44 with a low Gleason score between 3 and 6; n ϭ 38 with an intermediate Gleason score 7; and n ϭ 53 with a high Gleason score 8 to 10) for expression of PKP1-3 by immunofluorescence. The findings are summarized in Table 2 and Figure 5 . In summary, PKP1 expression was found less frequently and was generally lower in tumors with intermediate and high Gleason scores than in tumors with low Gleason scores, which was statistically highly significant (P ϭ 0.00006). In contrast, PKP3 expression was significantly more frequent and generally higher in adenocarcinomas with intermediate or high Gleason scores than in tumors with low Gleason scores, of which 37% were completely negative (P ϭ 0.0002). No major differences between the single groups were noted with regard to PKP2. There was no statistical correlation between PKP expression and prostate-specific antigen values (data not shown).
Representative immunofluorescence images for the presence of plakophilins in adenocarcinoma with low, intermediate, and high Gleason score are presented in Figure 6 . In tumors with a low Gleason score, PKP1 and PKP2 were localized between neighboring cells, and PKP3 was additionally noticed in the cytoplasm of glandular epithelial cells. In tumors with intermediate Gleason scores, PKP1 occurred only in larger, more regular shaped glands, whereas in smaller glands with a tendency of the epithelial cells to spread in the surrounding stroma, the PKP1 signal was lost, whereas PKP2 and PKP3 were still detectable. This observation was even more prominent in carcinomas with a high Gleason score: colocalization of PKP1 with keratin 8/18, as an epithelial cell marker, revealed large tumor areas negative for PKP1 (Figure 7) .
Effects of PKP3 Overexpression and Knockdown on DU 145 Cells
To analyze the potential functional consequences of overexpression of PKP3 in more aggressive tumors, we generated stable cell lines with modified expression of PKP3. We used the malignant cell line DU 145 and introduced cDNA constructs yielding either the overexpression of the fusion protein PKP3-EGFP ("gain of function") or reduced expression ("loss of function") through a shRNA interference approach. To knock down the expression of PKP3, two different target sequences were chosen yielding the cell clones shPKP3-9 and shPKP3-1350 with different RNA and protein levels of PKP3 (Supplemental Figure 2 , see http://ajp.amjpathol.org). In contrast, a cell clone stably expressing shRNA specific for luciferase showed RNA and protein levels comparable with untreated DU 145 cells. The cell clone, shPKP3-1350, with the higher knockdown efficiency was used for further analyses. When PKP3-EGFP was expressed in DU 145 cells, this protein was detected at cell-cell contacts in desmosomes as shown by colocalization with desmosomal proteins (eg, desmoglein) but also in a decent amount in the cytoplasm (Figure 8 ). In addition, a high portion of uncoupled cells was observed in stably transfected cells where the portion of cytoplasmic PKP3-EGFP was even higher. As a control, a PKP3-myc construct was introduced in DU 145 cells, and here, PKP3 fused to a smaller tag also occurred in desmosomes and in the cytoplasm (Supplemental Figure  3 , see http://ajp.amjpathol.org). In cell lines with knockdown of PKP3, the distribution of desmosomal proteins (eg, desmoglein) was also disturbed (Figure 8 ). Desmoglein was only rarely detectable in desmosomes and instead mostly localized in the cytoplasm in different sized structures. Taken together, our findings clearly showed that overexpression and knockdown of PKP3 interfered with the formation of desmosomes and thus with cell-cell contacts.
To further characterize the three cell lines with different PKP3 expression levels, untreated DU 145 cells, PKP3-EGFP expressing cells, and PKP3 knockdown cells (clone shPKP3-1350) in more detail, we compared the cell proliferation rate via BrdU incorporation. For cells overexpressing PKP3 a significant higher proliferation rate was noticed (Figure 9 ). This observation implies that PKP3 contributes to the regulation of cell growth and cell division.
Discussion
The present study demonstrates the presence of all three plakophilins, PKP1-3, in luminal and basal cells of the glandular epithelium of the prostate. In prostatic adenocarcinomas, PKP1 expression was decreased with increasing tumor grade, whereas the expression of PKP3 conversely was increased in tumors with high compared with low Gleason scores. PKP2 expression was similar in all tumors, irrespective of Gleason score. Interference with the level of PKP3 expression in a cell culture model influenced the formation of desmosomes and the proliferation rate.
In epithelia, the distribution of plakophilins can be considered as a marker for differentiation. Among the plakophilin family, PKP2 is the most widespread desmosomal plaque protein, occurring in simple, complex, and certain stratified epithelia. 5, 10 Another member less widely distributed is PKP3, which is found in desmosomes of most simple and almost all stratified epithelia and cell lines derived therefrom, with a remarkable exception of hepatocytes. 12, 13 In contrast, PKP1 is the least common plakophilin. It has been reported to occur in stratified epithelia, urothelium, and certain complex epithelia. 11, 29, 30 Until recently, any studies on the distribution of plakophilins in the glandular epithelium of the prostate were not available. We show for the first time by immunofluorescence, immunoelectron microscopy, and immunoblot the occurrence of all three plakophilins in luminal and basal cells of pseudostratified prostate epithelium. Similarly, PKP1 has been reported to occur in other glandular epithelia such as, for example, the inner dermal ductal cells in eccrine sweat glands 30 or the mammary gland ducts. 11 We analyzed 135 cases of prostatic adenocarcinomas and noticed a generally inhomogeneous expression of PKP1 in adenocarcinomas with intermediate (69%) or high (70%) Gleason score. In tumor areas with high Gleason pattern, PKP1 was no longer detectable, whereas the expression of the two other PKPs, PKP2 and PKP3, was either unchanged (PKP2) or even increased (PKP3). One previous study 31 reported the presence of all three plakophilins in prostate carcinomas but did not address the association with Gleason grading. In other human tumors, the expression of plakophilins seems to differ between different entities. In oropharyngeal tumors, a reduction or an absence of PKP1 and PKP3 in desmosomes has been noticed. 17 In contrast, non-small cell lung carcinomas were reported to show up-regulation of PKP3. 16 An inhomogeneous expression of PKP1 in tumors has been described in several reports, 18, 30, 32, 33 and it has been suggested that PKP1 functions as a differentiation marker for carcinomas. 30 In glandular epithelium, the detection of PKP1 might be a valuable indicator of well-differentiated glandular structures. Differences in the occurrence of PKPs (eg, loss, up-regulation, or inhomogeneous expression) could reflect tumor progression, as already noticed for protein p120. 15 By using DU 145 cultured cancer cells as a cell culture model, deduced from a brain metastasis of a prostatic adenocarcinoma, we interfered with the expression level of PKP3. Both the knockdown (loss of function) and the overexpression (gain of function) resulted in formation of fewer desmosomes, and the overexpression led to a higher proliferation rate. The essential importance of all three PKPs has been shown in vitro in cultured cells via knockdown approaches. 18, 34, 35 The down-regulation of PKP1 and PKP3 resulted in a decreased formation of desmosomes and increased cell motility and invasion. 18, 35 PKPs do not only contribute to formation and maintenance of desmosomes 22, 34, 36 but also function in the cyto-and nucleoplasm. 27 ,37 PKP2 has been found in nuclear particles containing RNA polymerase III. 37 Moreover, cytoplasmic PKP1 and PKP3 are components of RNA-containing particles and can be recruited to stress granules. 27 The overexpression of PKP3 led to a higher portion of PKP3 in the cytoplasmic pool and thereby may regulate cell growth and cell division and effect the formation of desmosomes. A deficiency in one of the PKPs has a tremendous impact on epithelial integrity in animals and humans. Ablation of PKP1 results in skin fragility and hypohidrotic ectodermal dysplasia. 38 Knockout PKP2 mice exhibit lethal alterations in heart morphogenesis.
39 PKP3-deficient mice develop hair coat abnormalities and are prone to cutaneous inflammation. 40 Clearly, future studies will have to reveal the function of PKP1 and 3 in the cytoplasm and how exchange of the junctional and nonjunctional form is regulated in healthy and diseased states such as, for example, cancer.
